Table 3 Logistic regression analysis of the presence of an increased C-IMT.

From: Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes

Serum FGF23 levels

Without an FHD

With a first-degree FHD

OR

95% CI

P

OR

95% CI

P

Per unit

1.016

1.002–1.030

0.026

1.030

1.000–1.060

0.047

An increased C-IMT

 Quartile 1

Reference

Reference

 Quartile 2

1.119

0.790–1.587

0.526

1.563

0.661–3.693

0.309

 Quartile 3

1.415

1.011–1.980

0.043

1.527

0.633–3.685

0.347

 Quartile 4

1.439

1.033–2.003

0.031

2.263

1.010–5.069

0.047

  1. Serum FGF23 levels: Quartile 1: ≤ 23.80 pg/mL; Quartile 2: 23.81–29.19 pg/mL; Quartile 2: 29.20–34.99 pg/mL; Quartile 4: ≥ 35.00 pg/mL.